I lead the UK’s busiest and most innovative stereotactic radiotherapy network. We treat >600 patients with SBRT every year and have fully integrated adaptive MR-guided radiotherapy into our programme, with nationally-leading expertise in oligometastatic disease and in pancreas, liver, central thorax and complex reirradiation.

I am a clinical oncologist with a focus on gastro-intestinal cancer and oligometastatic disease.I offer my patients integrated radiation and systemic therapies in the curative and palliative settings, including immunotherapy, IGRT, IMRT, SABR/SBRT and SIRT.Among my key achievements:🔹 Established and scaled the UK's largest SBRT practice for hepatocellular carcinoma🔹 Inaugurated the UK HPB Precision Radiotherapy Steering Group🔹 Deputy chief investigator… Show more I am a clinical oncologist with a focus on gastro-intestinal cancer and oligometastatic disease.I offer my patients integrated radiation and systemic therapies in the curative and palliative settings, including immunotherapy, IGRT, IMRT, SABR/SBRT and SIRT.Among my key achievements:🔹 Established and scaled the UK's largest SBRT practice for hepatocellular carcinoma🔹 Inaugurated the UK HPB Precision Radiotherapy Steering Group🔹 Deputy chief investigator on the WISTERIA study, which combined the DDR agent AZD1775 with adjuvant chemo-radiation for high risk HNSCC🔹 Immunotherapy safety lead on the CompARE study combining durvalumab with chemo-radiation for oropharyngeal cancer🔹 Top global recruiter to the HAWK immunotherapy study in advanced head/neck cancer Show less